Compare CDNA & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNA | BKV |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2007 | 2022 |
| Metric | CDNA | BKV |
|---|---|---|
| Price | $66.83 | $21.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $58.83 | $34.00 |
| AVG Volume (30 Days) | 1.0M | ★ 2.1M |
| Earning Date | 11-03-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 199.00 |
| EPS | ★ 2.13 | 1.11 |
| Revenue | $48,324,000.00 | ★ $893,781,000.00 |
| Revenue This Year | $30.36 | $46.52 |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | $30.04 | ★ $19.63 |
| Revenue Growth | 18.93 | ★ 47.85 |
| 52 Week Low | $13.95 | $20.08 |
| 52 Week High | $65.50 | $32.81 |
| Indicator | CDNA | BKV |
|---|---|---|
| Relative Strength Index (RSI) | 78.88 | 32.89 |
| Support Level | $17.26 | N/A |
| Resistance Level | N/A | $27.40 |
| Average True Range (ATR) | 2.87 | 0.82 |
| MACD | 0.90 | -0.20 |
| Stochastic Oscillator | 99.39 | 9.49 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
BKV Corp is a growth-driven energy company focused on the development of natural gas-producing assets, the ownership and operation of natural gas-fired power generation assets, and selective accretive acquisitions. The company's core businesses are the production of natural gas and the generation of natural gas-fired power from its owned and operated assets, supported by a closed-loop plan, enabled by its upstream, midstream, power, and CCUS businesses.